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Purpose. To investigate the in vivo incision architecture using spectral domain optical coherence tomography (SD-OCT) in 23-gauge
and 25-gauge transconjunctival sutureless pars plana vitrectomy (TSPPV).Methods. A prospective observational study of 22 eyes of
22 patients that underwent three-port 25-gauge (10 eyes) or 23-gauge (12 eyes) TSPPVwas performed.The three sclerotomies sites in
each eye were analyzed by Corneal Adapter Model (CAM) RTVue SD-OCT (Optovue Inc., Fremont, CA, USA) with wound cross-
section images (longitudinal and transversal) on days 1, 7, and 30 postoperatively. Transversal and longitudinal length, location,
angle between the conjunctival surface tangent and the incision plane, and architecture deformations were evaluated. Results. All
patients (22 eyes) completed the study and surgeries lasted less than 60 minutes. All wounds were obliquely performed, 23-gauge
mean anglewas 23± 5∘, and 25-gauge angulewas 21± 4∘. Twenty-three-gauge sclerotomy transversalmean lengthwas 1122± 242 𝜇m
and 25-gauge transversal sclerotomy mean length was 977± 174𝜇m; 23-gauge longitudinal mean length was 363 ± 42𝜇m and
25-gauge longitudinal sclerotomy mean length was 234±19𝜇m; 23-gauge open wound thickness mean was 61± 28 𝜇m and 25-
gauge open wound thickness mean was 22± 6𝜇m. All results were statistically significant (𝑃 < 0.05). No vitreous incarceration or
silicone oil residue was observed in incision sites with both gauges. Conclusions. The 23-gauge and 25-gauge architectural wound
constructions were well visualized using CAM SD-OCT. Statistical differences between the two gauges were observed throughout
the study period.
1. Introduction
Transconjunctival sutureless pars plana vitrectomy (TSPPV)
has considerably transformed the outlook of patient man-
agement in the field of retina and vitreous surgery since
when described in 2002 [1, 2]. At first, the cannulas were
introduced straight through the sclera at the sclerotomy sites
in a perpendicular fashion. However, with this technique
questions have been raised regarding to the true self-sealing
characteristics of some of these TSPPV, with reports of
increased hypotony and endophthalmitis rates associated [3–
9]. The creation of the beveled opposed to a straight scle-
rotomy incision to prevent leakage through these sutureless
wounds was a greater advantage for the procedure [10–14].
But the limitations of the instruments, fluidics, extensive
flexibility of the instruments, and poor illumination caused
by a small lumen 0.5mm caliber reduced the use of 25-gauge
TSPPV, even with advantages over the traditional techniques
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Figure 1: Images of the 25-gauge sclerotomies on postoperative. A
cross line scan parameters of transverse and longitudinal measure-
ments illustrated with a diagrams.
such as reduced surgical trauma, improved postoperative
comfort, faster visual recovery, shorter operating times, and
reduced postoperative astigmatism [2, 15, 16].This procedure
became increasingly most commonly used when 23-gauge
TSPPV was introduced to overcome the limitations of 25-ga
describe above [17–20].
However, there still exists debate of the self-sealing char-
acteristics of TSPPV with respect to the best wound archi-
tecture construction. Recently, ultrasound biomicroscopy
(UBM) [21] and time-domain optical coherence tomography
(OCT) [22–24] have been used to evaluate wound architec-
ture in vivo. The aim of this study was, therefore, to use the
high-resolution anterior segment (AS) spectral domain OCT
(SD-OCT) to investigate the wound architecture of both 23-
ga and 25-gauge TSPPV in order to gain further insight into
the sclerotomy wound construction.
2. Materials and Methods
Twenty-two consecutive patients (minimum age: 18 years
old) have undergone primary TSPPV 23-gauge or 25-
gauge using one-step Alcon/Grieshaber trocar cannula set
(Alcon/Grieshaber, Alcon Laboratories, Inc., Fort Worth,
TX, USA) and Accurus 400 VS vitreous machine (Alcon
Laboratories, Inc., Fort Worth, TX, USA). In this study we
used the new generation of the trocar cannula set that is
composed of trocar and metal cannula, different from the
oldest generation that is composed of polymer cannula for
the 25-gauge set. The surgical parameters were for 23-gauge:
1800–2500 cuts per minute (CPM) and 200–400mmHg
of vacuum—using 3D parameter; and 25-gauge: 1800–2500
CPM and 400–600mmHg of vacuum—using 3D parameter.
Study participants were recruited from the clinical practices
by the coauthors AT and CS according to a prospective
study protocol approved by the institutional review board.
Informed consent was obtained and documented for every
participant. The study adhered to the tenets of Declaration
of Helsinki. The eye was randomly selected for each gauge,
and all TSPPV surgeries were performed by the same surgeon
(AT), within less than 60minutes. Exclusion criteria included
history of previous pars plana vitrectomy surgery.
Demographics of patients, diagnoses, and type of proce-
dures performed were also recorded. Anatomical outcomes
and any postoperative complications, especially sclerotomy-
related ones, were specifically evaluated. A spectral-domain
OCT system (RTVue, Optovue Inc., Fremont, CA) with a
corneal adaptor module (CAM) was used to image the scle-
rotomies on postoperative days 1, 7, and 30. A crossline scan
pattern was used to measure the scleral incisions positioning
the caliper mark perpendicularly to the limbus.
A conventional three-port vitrectomy was performed
with a straight angled incision of 20 degrees to 30 degrees
in all patients; the wound locations were superotemporal,
superonasal, and inferotemporal in all eyes. Measurements
of the transversal and longitudinal incision length and of
the angle formed between the conjunctival surface tangent
and the incision plane were taken; besides, information
about location and architecture deformations was collected
(Figure 1). SAS V9.1 programming language (SAS Institute
Inc., Cary, NC, USA) was used for statistical analyses.
Accepted level of significance for all tests was a P value of less
than 0.05.
3. Results
Average patient age at time of surgery was 65.1 years ± 15.1
(range 36–83 years). Ten patients were men. Thirty 25-gauge
sclerotomies of ten eyes and thirty-six 23-gauge sclerotomies
of 12 eyes were analyzed. Indications for surgery were epireti-
nal membrane (4), rhegmatogenous retinal detachment (RD)
(4), tractional RD (8), and macular hole (6). Combined
phacoemulsification and IOL implantation through clear
corneal incision were performed in 2 eyes with RD. All
cataract incisions were performed after the infusion trocar
was placed. 10–0 nylon suture was used at the corneal incision
to prevent anterior chamber collapse during the cannula
insertion. There was no failure in cannula insertion due to
hypotony or anterior chamber collapse. In two patients with
RD a silicone intraocular injection after vitrectomy (one for
each gauge) was necessary. All patients with RD underwent
TSPPV without scleral buckle.
No intraoperative suture placement was necessary and no
patient had hypotony on the first postoperative day. The IOP
was normal in all postoperative visits (range: 12 to 22mmHg).
All three incisions of each eye were evaluated using SD-
OCT to define incision on postoperative days 1, 7, and 30.
Transversal and longitudinal length, location, angle formed
between the conjunctival surface tangent and the incision
plane, and architecture deformations were evaluated. All
wounds were obliquely performed, 23-gauge mean incision
angle was 23 ± 5∘ (range: 37 to 5 degrees), and in 25-gauge,
21 ± 4
∘ (range: 31 to 4 degrees). Mean transversal sclerotomy
length was 1122 ± 242 𝜇m with 23-gauge (range: 1781 to 283)
and 977 ± 174 𝜇m (range: 1650 to 174) with 25-gauge. Mean
longitudinal sclerotomy length was 363 ± 42 𝜇m (range: 543
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Figure 2: Spectral domain OCT images (RTVue with a corneal adaptor module-CAM fromOptovue Inc., Fremont, CA) at the postoperative
period of 23-gauge sutureless pars plana vitrectomy. (A) Longitudinal (upper) and transversal (bottom) lengthmeasurement at the sclerotomy
incision, on postoperative day 1. (B) Longitudinal (upper) and transversal (bottom) length measurement at the sclerotomy incision, on
postoperative day 7. (C) Longitudinal (upper) and transversal (bottom) length measurement at the sclerotomy incision, on postoperative
day 30.
Figure 3: Spectral domain OCT images (Optovue with Cornea Camera) at the postoperative period of 25-gauge sutureless pars plana
vitrectomy. (A) Longitudinal (upper) and transversal (bottom) length measurement at the sclerotomy incision, on postoperative day 1. (B)
Longitudinal (upper) and transversal (bottom) length measurement at the sclerotomy incision, on postoperative day 7. (C) Longitudinal
(upper) and transversal (bottom) length measurement at the sclerotomy incision, on postoperative day 30.
to 42) with 23-gauge, and 234 ± 19 𝜇m (range: 265 to 19) with
25-gauge.Mean openwound thicknesswas 61±28 𝜇m(range:
543 to 42) with 23-gauge and 22 ± 6 𝜇m (range: 48 to 6) with
25-gauge. All results were statistically significant (𝑃 < 0.05).
No vitreous incarceration or silicone oil residue was observed
in incision sites with both gauges (Figures 2 and 3), and no
architectural structure difference was observed comparing
macular to RD cases. Tables 1 and 2 describe transversal and
longitudinal results for all gauges.
4. Discussion
Chen first described sutureless self-sealing sclerotomies in
1996 [25]. After that, other authors have described their
experience and technique modification [1, 2, 17, 26]. Twenty-
three and 25-gauge tunnel incision cannulas require no suture
because of a reduced diameter, 0.5mm [1] and 0.72mm
[17], respectively, placed obliquely to the scleral surface. The
longitudinal length of the sclerotomy was around 50% of the
lumendiameter of the gauges.Onpostoperative days 1 and 30,
the incision length showed low variance, suggesting that the
scleral fibers were partially cut and partially dissectedwithout
damage, suggesting no variation during those days (Table 1).
Imaging exams, such asUBM [21] andAS-OCT, serve as a
tool to produce clear cross-sectional images of the pars plana,
including vitreous base.These regions are difficult to examine
adequately using lenses and/or slit lamp, and it may be useful
to locate the sclerotomy site [27]. Boker and Spitznas reported
the use of UBM to examine the sclerotomy site after PPV
[28]. In a series of 20 eyes of 19 patients, the entry sites were
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Table 1: Transversal length of sclerotomy incisions after transconjunctival sutureless pars plana vitrectomy performed with 23-gauge and
25-gauge measured with SD-OCT at the postoperative followup.
23-gauge (microns)
Average ± SD
25-gauge (microns)
Average ± SD 𝑃 value
Postoperative day 1 1117 ± 247 977 ± 205 0.03
Postoperative day 7 1120 ± 234 944 ± 144 0.04
Postoperative day 30 1129 ± 254 944 ± 144 0.003
Total 1122 ± 242 974 ± 174 0.04
Table 2: Longitudinal length of sclerotomy incisions after transconjunctival sutureless pars plana vitrectomy performed with 23-gauge and
25-gauge measured with SD-OCT at the postoperative followup.
23-gauge (microns)
Average ± SD
25-gauge (microns)
Average ± SD 𝑃 value
Postoperative day 1 375 ± 39 236 ± 18 <0.001
Postoperative day 7 357 ± 37 233 ± 23 <0.001
Postoperative day 30 355 ± 49 233 ± 23 <0.001
Total 363 ± 42 234 ± 19 <0.001
identified by UBM, and the authors concluded that UBMwas
useful in determining possible sources of complications after
vitrectomy and could give further insight into the interactions
between pars plana sclerotomy and anterior fibrovascular
proliferation [29]. The major shortcoming of UBM is that
the direct pressure of the open immersion cup on the
incisions could alter the observed architecture and increase
the potential risk of endophthalmitis, especially in the early
postoperative period [22]. The risk of compression with the
UBM exam can possibly be reduced using the ClearScan
bag/balloon available.
Some authors demonstrated the importance of the
oblique incisions in vitro studies where angled incisions were
superior at histopathology and in AS-OCT [14, 23, 30]. Taban
et al. using time domain AS-OCT imaging demonstrated
that 23-gauge sutureless vitrectomy performed using oblique
(angled) incisions provided adequate wound closure evident
even on postoperative day one [23].
Anterior segment OCT is a noncontact and noninva-
sive imaging exam and considered for serial examination.
Time domain AS-OCT is well suited to examine sutureless
vitrectomy incisions in the immediate postoperative period,
with adequate penetration depth and low resolution [22]. SD-
OCT images obtained not only clearly showed the profile
of the incisions with a high resolution that allowed accurate
measurement of parameters such as incision length and angle,
but also identified the fine architectural features identified
by the authors as wound opening thickness. SD-OCT has a
limitation related to depth.
In the present study, we were able to identify the three
sclerotomy sites with SD-OCT using the corneal camera. All
wounds were obliquely built with a safety angle of entrance,
longitudinal diameter was close to 50% of the cannula lumen,
and transversal wound length (distance between the external
and internal scleral limits) was around 1mm. There was
an adequate wound closure with a hyporeflective signal
corresponding to an open wound thick scar. All results
were statistically significant showing difference between the
wound architecture comparing sutureless vitrectomywith 23-
gauge and 25-gauge.
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